Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes in Adiposity and Metabolic Measures During Medication Switches to Aripiprazole From Other Atypical Antipsychotics

NCT00205660 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00205660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes in Adiposity and Metabolic Measures During Medication Switches to Aripiprazole From Other Atypical Antipsychotics
Lead sponsor
Washington University School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2005
Completion date
August 31, 2009
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia, type 2 diabetes mellitus